Invention Grant
- Patent Title: Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
-
Application No.: US16537342Application Date: 2019-08-09
-
Publication No.: US10653765B2Publication Date: 2020-05-19
- Inventor: Camille Locht , Bernard Mahon , Heather Kavanagh
- Applicant: Institut National de la Santé et de la Recherche Médicale (INSERM) , Institut Pasteur de Lille , National University of Ireland Maynooth
- Agent Stanley A. Kim
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@67a70f06
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61P31/04 ; A61K39/00
Abstract:
The present invention relates to a life attenuated Bordetella pertussis vaccine which is deficient for tracheal cytotoxin (TCT), pertussis toxin (PTX), and dermonecrotic toxin (DNT) for prophylaxis or treatment of an allergen-driven airway pathology.
Information query
